Stay updated on TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial

Sign up to get notified when there's something new on the TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Added a comprehensive Locations section listing sites across many states and countries and updated the revision to v3.3.3.
    Difference
    0.4%
    Check dated 2025-12-21T21:44:35.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision: v3.3.2 replaces Revision: v3.3.1 on the page; this is a minor UI/version label update and does not affect study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-30T06:15:39.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The changes include an addition noting PubMed auto-fill for publications (which may not be about the study) and a deletion clarifying PubMed-originated publications automatically created by ClinicalTrials.gov using the NCT Number, with the revision updated to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-23T07:28:14.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The study location listing was updated from 'Tainan City, Taiwan, 704' to 'Tainan, Taiwan, 704' by adding the new location and removing the older one. A funding notice banner was removed.
    Difference
    0.1%
    Check dated 2025-11-16T05:14:12.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    External resource links at the bottom of the Study Details page were removed, including DailyMed, PubMed searches, vivli, and several government sites. This reduces quick access to supporting documents but does not change the core study information such as eligibility, design, outcomes, or locations.
    Difference
    0.2%
    Check dated 2025-11-01T20:34:21.000Z thumbnail image
  9. Check
    93 days ago
    Change Detected
    Summary
    Major update to version 3.2.0 accompanied by a government-status notice; removes the old v3.1.0 reference and adds operating-status details.
    Difference
    1%
    Check dated 2025-10-04T00:43:46.000Z thumbnail image

Stay in the know with updates to TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial page.